Drug Approval | November 29, 2025
Innoxel Lifesciences completes EU GMP inspection by Belgium's FAMHP
The audit was completed with zero critical and zero major observations
The audit was completed with zero critical and zero major observations
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
The fresh capital will propel Cordance into its first-in-human clinical trial
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Renalyx will continue operating as an independent unit within the group
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
Subscribe To Our Newsletter & Stay Updated
